Literature DB >> 2644013

Primary adrenal lymphoma.

G J Harris1, F O Tio, D D Von Hoff.   

Abstract

A case of non-Hodgkin's lymphoma (large cell immunoblastic sarcoma) arising as a primary malignancy in the adrenal gland is reported and the literature concerning this unusual tumor is reviewed. Although extremely rare, it is possible to make the diagnosis preoperatively. Therefore, primary adrenal lymphoma should be included in the differential diagnosis of a suprarenal mass.

Entities:  

Mesh:

Year:  1989        PMID: 2644013     DOI: 10.1002/1097-0142(19890215)63:4<799::aid-cncr2820630432>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Bilateral adrenal masses.

Authors:  E Lopez; G Piédrola; L Villalon
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

2.  [Primary bilateral, adrenal, highly malignant B-cell lymphoma with lymphoblastic mengiosis].

Authors:  G M Robertz-Vaupel; A G Glasmacher; J Vogel; H A Vaupel; O Köster; L Pizzulli
Journal:  Klin Wochenschr       Date:  1990-11-09

3.  Primary adrenal lymphoma: Differential involvement with varying adrenal function.

Authors:  Shiekh Aejaz Aziz; Bashir Ahmad Laway; Imran Rangreze; Mohd Iqbal Lone; Syed Nisar Ahmad
Journal:  Indian J Endocrinol Metab       Date:  2011-07

4.  Primary adrenal lymphoma causing hypoaldosteronism in a cat.

Authors:  Jessica F Romine; Angela R Kozicki; Marc S Elie
Journal:  JFMS Open Rep       Date:  2016-12-01

5.  Systemic and prophylactic intrathecal chemotherapy for primary adrenal lymphoma: A retrospective study of 20 case reports.

Authors:  Lei Yuan; Lu Sun; Jian Bo; Quanshun Wang; Yu Zhao
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

6.  Comparison of acquired cystic kidney disease between hemodialysis and continuous ambulatory peritoneal dialysis.

Authors:  J H Park; Y O Kim; J H Park; B S Kim; S A Yoon; C W Yang; Y S Kim; C H Han; B S Kim; B K Bang
Journal:  Korean J Intern Med       Date:  2000-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.